ArticleClinical proteomics2018

Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.

Chen Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.